HemoGenix Announces the Release of OxyFLOW

HemoGenix has made available its proprietary OxyFLOW Research Kit. HemoGenix, in collaboration with Biotrin International, developed a flow cytometric assay for detecting and quantifying oxidative DNA damage to lympho-hematopoietic cells. OxyFLOW is an assay platform that detects oxidative DNA damage as a result of stress, xenobiotics and the administration of drugs.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/02-07-2005/0002983541&EDATE=)